Related Experiment Video

Updated: Aug 14, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

Defective downregulation of receptor tyrosine kinases in cancer

Kristi G Bache1, Thomas Slagsvold, Harald Stenmark

  • 1Department of Biochemistry, Norwegian Radium Hospital, Montebello, Oslo, Norway.

The EMBO Journal
|July 2, 2004
PubMed

Insights

Impaired deactivation of receptor tyrosine kinases (RTKs) contributes to cancer. Deregulation of the ubiquitin-mediated machinery for RTK endocytosis and degradation is implicated in this process.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Growth factors regulate cell functions via receptor tyrosine kinases (RTKs).
  • RTK overactivation is linked to cancer, but impaired deactivation is also a key mechanism.
  • Receptor downregulation, through endocytosis and lysosomal degradation, is a major RTK deactivation pathway.

Purpose of the Study:

  • To discuss the role of impaired RTK deactivation in cancer.
  • To highlight the importance of the ubiquitin-mediated machinery in RTK regulation.
  • To present evidence implicating deregulation of this machinery in carcinogenesis.

Main Methods:

  • Review of existing literature on RTK signaling and cancer.
  • Analysis of the molecular mechanisms of receptor endocytosis and degradation.
  • Examination of the role of ubiquitin in RTK regulation.

Main Results:

  • Impaired deactivation of RTKs, not just overactivation, is implicated in cancer development.
  • The ubiquitin-proteasome system plays a critical role in RTK downregulation.
  • Evidence suggests that disruptions in this regulatory machinery contribute to cancer.

Conclusions:

  • Dysregulation of the ubiquitin-mediated RTK deactivation pathway is a significant factor in cancer.
  • Targeting this machinery could offer novel therapeutic strategies for cancer treatment.
  • Further research into RTK degradation pathways is crucial for understanding and combating cancer.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...